673 fundamentals
An in-depth look to CEREVEL THERAP.HLDGS operating, investing, and financing activities
673 free cash flow for Q1 24 is -111.16 M EUR. For 2023, 673 free cash flow was -313.58 M EUR and operating cash flow was -310.13 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM